General Comments
All amino acids and resins were purchased from either Novabiochem (Merck) or SigmaAldrich. All amino acids were N-Fmoc protected and side chains were protected with Boc (Lys, Trp); OtBu (Asp, Glu, Ser, Thr); Trt (Cys, Asn, Gln); Pbf (Arg). BID-Cys and BID-hCys peptides were purchased from Severn Biotech Ltd. Syntheses of peptides were carried out in the Liberty CEM Peptide Synthesiser with or without microwave assistance. All solvents used were of ACS grade from Sigma-Aldrich.
UV absorbance analyses were recorded in a 1 mm path-length quartz cuvette on a Perkin Elmer Lambda 900 UV/VIS/NIR spectrometer.
High-resolution mass spectrometry (HRMS) data was recorded using electrospray ionization in positive mode (ESI + ) with a Bruker MaXis Impact spectrometer.
LC-MS analyses were conducted on a Thermo Scientific Ultimate 3000 using UHPLC + technology. All experiments were run through a Kinetex C-18 50x2.1 mm LC-Column, 2.6 m particle size, for small molecules using a 5-95% gradient (acetonitrile:water, 0.1% formic acid) over 1.7 min and an Aeris Peptide XB-C18 100x2.1 mm LC-Column, 2.6 m particle size, for peptides using a 5-95% gradient (acetonitrile:water, 0.1% formic acid) over 3.6 min for positive ion spectra. Samples were ionized by electrospray.
Analytical HPLC experiments were performed using an Agilent 1290 Infinity LC series system equipped with an Ascentis Express Peptide ES-C18 100x2.1 mm column, 2.7 m particle size on a 5-95% gradient (acetonitrile:water, 0.1% formic acid) over 5 min.
CD data were recorded using an Applied Photophysics Chirascan Instrument and Software in a 1 mm path-length quartz cuvette. For each scan, the following parameters were used: 180-260 nm range; point time 1 s; 1 nm per point; step = 1; bandwidth 5 nm; temperature 20 °C. Scans were performed in triplicate.
Fourier-transform infrared absorption spectroscopy (IR) was performed on Bruker Platinum-ATR system equipped with an Alpha FT-IR spectrometer. Maximum absorbances are reported for significant bands in cm -1 .
Synthesis of S peptides
The series of S peptides (WT-S 8, OX-S-Cys 2c and OX-S-hCys 2d) (1 eq., 0.1 mmol) were synthesized on Rink Amide MBHA resin (Loading Capacity 0.36 mmol g -1 ) using HCTU and DIPEA in DMF for amide coupling, and 20% piperidine in DMF for the deprotection using a Liberty CEM Peptide Synthesiser without microwave assistance. Each amino acid was coupled twice for 30 min at room temperature.
After the final amino acid coupling and deprotection, a solution of acetic anhydride (10 equiv.) and DIPEA (10 equiv.) in DMF (2 mL) was manually transferred to the resin. After 2 h, the resin was drained, washed with DMF (5 × 2 mL × 2 min), CH 2 Cl 2 (5 × 2 mL × 2 min) and then Et 2 O (3 × 2 mL × 2 min).
Peptides were simultaneously cleaved from the resin and side-chain deprotected with cleavage 'Reagent K' TFA:EDT:Thioanisole:Phenol:H 2 O, 82:3:5:5:5 (3 × 2 mL × 1 h). The resin was washed with fresh TFA (2 mL × 2 min) and the solution concentrated in vacuo. The resulting oils were precipitated with ice-cold ether (5 mL) and placed in a centrifuge (3000 rpm × 3 min). The supernatants were removed, the precipitate rinsed with ice-cold ether (3 × 10 mL) and dried in vacuo.
Crude peptides were suspended in dimethylsulfoxide at an approximate concentration of 10 mg mL -1 . Purification was performed using a mass-directed HPLC with a Jupiter Proteo preparative column on a gradient of 20-45% acetonitrile/water (with 0.1% formic acid) for 35 min at a flow rate of 10 mL min -1 with S peptides eluting at 16-18 minutes. Fractions were checked by LCMS, concentrated in vacuo and lyophilised.
WT-S peptide -8
The compound 8 was obtained using mass-directed preparative HPLC with purity higher than 95% (5.2 mg, 38%). 
OX-S-Cys peptide -2c
The compound 2c was obtained using mass-directed preparative HPLC with purity higher than 95% (6.3 mg, 27.1%). 
OX-S-hCys peptide -2d
The compound 2d was obtained using mass-directed preparative HPLC with purity higher than 95% (8.1 mg, 22.2%). General procedure for the synthesis of reversible constrained peptides
Synthesis of RED-peptides from OX-peptides -STEP 1
A solution of OX-peptide (1 eq.) in a mixture of water/acetonitrile (1 mL/0.1 mL per 0.8 µmol) was prepared in a 5 mL vial, to which was added a 10 mM solution of TCEP . HCl (1 eq.) in acetonitrile. The resulting mixture was stirred for 30 minutes at room temperature until completion; the reaction was monitored by HRMS.
Synthesis of STA-peptides -STEP 2
From the crude solution, or a fresh solution of RED-peptide (1 eq.) in a mixture of water/acetonitrile (1 mL/0.1 mL per 0.4 mol) in a 5 mL vial, was added a 10 mM solution of dibromomaleimide (1 eq.) in acetonitrile. The resulting mixture was stirred for a few hours at room temperature until completion; the reaction was monitored by HRMS. The crude solution was directly injected onto the mass directed HPLC for purification. The desired peptide was collected by mass using a Jupiter Proteo preparative column (reversed phase) on an increasing gradient of acetonitrile to water (plus 0.1% formic acid v/v in both solvents) at a flow rate of 10 mL.min -1 .
Synthesis of OX-peptides from STA-peptides -STEP 3
From the crude solution of STA-peptide (1 eq.) in a mixture of water/acetonitrile (1 mL/0.1 mL per 0.4 mol) in a 5 mL vial was added an excess of thiol* (26 eq.). The resulting mixture was stirred overnight and the reaction was monitored by HRMS.
*thiol: -mercaptoethanol, glutathione.
HRMS spectra
BID-Cys -a Each step of this series of reactions has a quantitative conversion. STA-BID-Cys 2a was further purified by mass-directed HPLC for biophysical assay with purity higher than 95% (1.2 mg, 52%). 
BID-hCys -b
Each step of this series of reactions has a quantitative conversion. STA-BID-hCys 2b was further purified by mass-directed HPLC for biophysical assay with purity higher than 95% (2.1 mg, 47%). 
S-Cys -c
Each step of this series of reactions has a quantitative conversion. STA-S-Cys 2c was further purified by mass-directed HPLC for biophysical assay with purity higher than 95% (0.97 mg, 65%). 
S-hCys -d
Each step of this series of reactions has a quantitative conversion. STA-S-hCys 2d was further purified by mass-directed HPLC for biophysical assay with purity higher than 95% (1.1 mg, 56%). 
Modulation of the constraint

Synthesis of OX-BID-hCys 2b from STA-BID-hCys -3b
The STA-peptides can be unconstrained to give the RED-peptides and constrained again through a disulphide bond giving the OX-peptides.
Oxygen was directly bubbled into the crude solution of RED-BID-hCys 1b (1 eq., 1.1 mg, 0.4 mol) in a mixture of water/acetonitrile (1 mL/0.1 mL) in a 5 mL vial for 5 min to give OX-BID-hCys 2b. The reaction was monitored by LCMS ( Figure S 8 ).
Each step of this series of reactions has a quantitative conversion. 
Synthesis of the non-reversible constrained peptide -Suc-STA-S-hCys -9
The RED-peptides can be irreversibly constrained by adding using dibromomaleimide with an excess of reducing agent, leading to a succinimide cross-link.
From the crude solution solution of RED-S-hCys 1d (1 eq., 2 mg, 1.13 µmol) in a mixture of water/acetonitrile (1.6 mL/ 0.4 mL) in a 5 mL vial, was added a 10 mM solution of dibromomaleimide (1 eq., 170 L, 1.13 µmol) in acetonitrile. The resulting mixture was stirred for 2 hrs at room temperature. TCEP . HCl (5 eq., 1.6 mg, 5.65 mol) was then added to give in 8 hrs Suc-STA-S-hCys 9. An excess of thiol* (26 eq.) was added to the reaction mixture and Suc-STA-S-hCys 9 remained intact; the reaction was monitored by HRMS ( The spectral data were identical to those reported previously. [1] 
Synthesis of azide clickable intermediates I -VI
tert-butyl-(3-bromopropyl)carbamate -I
To a cooled suspension of 3-bromopropylamine hydrobromide (5 g, 22.8 mmol, 1 eq.) and ditert-butyl dicarbonate (5 g, 22.8 mmol, 1 eq.) in CH 2 Cl 2 (11 mL), triethylamine (6.4 mL, 45.6 mmol, 2 eq.) was added dropwise. The reaction mixture was stirred overnight at room temperature. After wich the reaction mixture was washed with a 1 M solution of HCl (2 x 10 mL) and H 2 O (2 x 10 mL). The organic layer was dried over MgSO 4 , filtrated and evaporated under reduced pressure affording the product as a yellow oil (3 g, 13.3 mmol, 58% The spectral data were identical to those reported previously. [2, 3] tert-butyl-(3-azidopropyl)carbamate -II The spectral data were identical to those reported previously. [2, 3] N-(3-azidopropyl)-2,2,2-trifluoroacetamide -III Special care was taken considering this product could be potentially explosive. It was stored at 0 °C, never heated over 40 °C and any impact or grinding with metal was avoided.
The spectral data were identical to those reported previously. [2, 3] 
5-(3-(3-azidopropyl)thioureido)-2-(6-hydrodroxy-3-oxo-3H-xanthen-9-yl)benzoic acid -IV
Fluorescein isothiocyanate isomer I (199 mg, 0.5 mmol, 1 eq.) was dissolved in anhydrous THF (20 mL) and triethylamine (171 μL, 1.2 mmol, 2.4 eq.) was added followed by the TFA salt IV (100 mg, 0.6 mmol, 1.2 eq. The spectral data were identical to those reported previously. [2] N-(3-azidopropyl)-5-((3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d The spectral data were identical to those reported previously. [3] Click chemistry on stapled peptides
Synthesis of yne-STA-BID-Cys -6
From the crude solution, or a fresh solution of OX-peptides (1 eq.) in a mixture of water/acetonitrile (1 mL/0.1 mL per 0.4 mol) was prepared in a 5 mL vial, to which was added a 10 mM solution of N-propargyl-2,3-dibromomaleimide 5 (1 eq.) in acetonitrile. The resulting mixture was stirred for 20 minutes at room temperature until completion; the reaction was monitored by HRMS. The crude solution was evaporated under reduced pressure to afford the clickable peptide 6 (quantitative) as a yellow solid. 
Synthesis of biotinylated STA-BID peptide by click chemistry -7a
A solution of yne-STA-BID-Cys 6 (0.79 mg, 0.28 mol, 1 eq.) was prepared in a 5 mM phosphate buffer (pH = 7.5) (78 L) in a 1 mL vial, to which was added a 30 mM solution of biotin azide V (18 L, 0.56 mol, 2 eq.), a 50 mM solution of sodium ascorbate (3 L, 0.14 mol, 0.05 eq.) in water and a 50 mM solution of CuSO 4 . 5H 2 O (1.1 L, 0.05 mol, 0.2 eq.) in water. The resulting mixture was heated to 50 °C for 1 min and stirred for 2 hrs at room temperature to afford 7a (quantitative); the reaction was monitored by HRMS. 
Synthesis of fluorescein conjugated STA-BID by click chemistry -7b
A solution of yne-STA-BID-Cys 6 (2.4 mg, 0.96 mol, 1 eq.) was prepared in DMSO (100 L) in a 1 mL vial, to which was added a 72 mM solution of FITC-Azide IV (51 µL, 3.84 µmol, 4 eq.) in DMSO, a 50 mM solution of CuI (20 µL, 0.96 µmol, 1 eq.) in CH 3 CN, a 50 mM solution of sodium ascorbate (41 µL, 1.92 µmol, 2 eq.) in water and a 50 mM solution of DIPEA (20 µL, 0.96 µmol, 1 eq.) in water. The resulting mixture was stirred overnight at room temperature to afford 7b (quantitative); the reaction was monitored by HRMS. 
Synthesis of pegylated STA-BID peptide by click chemistry -7c
A solution of yne-STA-BID-Cys 6 (0.79 mg, 0.28 mol, 1 eq.) was prepared in a 5 mM phosphate buffer (pH = 7.5) (78 L) in a 1 mL vial, to which was added a 30.8 mM solution of O-(2-Azidoethyl)heptaethylene glycol (18 µL, 0.56 mol, 2 eq.) in DMSO, a 50 mM solution of sodium ascorbate (3 µL, 0.14 mol, 0.5 eq.) in water and a 50 mM solution of CuSO 4 . 5H 2 O (1.1 L, 0.05 mol, 0.2 eq.) in water. The resulting mixture was heated to 50 °C for 1 min and stirred for 2 hrs at room temperature to afford 7c (quantitative); the reaction was monitored by HRMS. 
Determination of the concentrations of purified peptides
Peptides were lyophilised after purification by HPLC. The calculation of peptide concentration based on their weight was uncertain as lyophilised peptides might contain bound water. Peptide concentration can be accurately determined by UV absorbance based on the extinction coefficient of its residues. A standard for the maleimide cross-link was needed to use in calculations of the constrained peptide extinction coefficient. The adduct between two molecules of glutathione and the maleimide cross-link was therefore synthesised on gram scale.
Synthesis of maleimide(glutathione) 2 -VII
To a solution of glutathione (512 mg, 1.67 mmol, 2.5 eq.) in a mixture of water/acetonitrile (25 mL/ 25 mL) was added dibromomaleimide (169 mg, 0.67 mmol, 1 eq.). The resulting mixture was stirred for 4 h at room temperature; the reaction was monitored by HRMS. Solvents were evaporated under reduced pressure. The crude residue was dissolved in a minimum of water and was directly injected on the mass directed HPLC for purification. The desired maleimide adduct VII was collected by mass using a Jupiter Proteo preparative column (reversed phase) on a 5% to 95% gradient of acetonitrile to water (plus 0.1% formic acid v/v in both solvents) at a flow rate of 10 mL.min -1 (590 mg, 50 % 
Proteolysis studies on BID peptides
Trypsin, modified sequencing grade from bovine pancreas (lyophilized powder, MW = 24 kDa, ≥ 4 units/mg protein) was purchased from Sigma-Aldrich and used without further purification. BID peptides (200 M stock in PBS buffer pH 7.50, 5% DMSO) were treated with Trypsin (0.02 M stock solutions in PBS buffer pH 7.50) in a 1:10000 enzyme/substrate ratio. The degradation was followed with LCMS (Aeris Peptide LC-Column XB-C18 2.6 m, 100x2.1 mm, injection volume: 5 L, acetonitrile/water (0.1% formic acid) 5-95% gradient).
The degradation pattern of each peptide (figure A) could be identified by mass spectrometry. The cleavage sites are marked by dotted lines and the subsequent fragment masses, shown in squares, are allocated to a number which is reported on the LCMS graph (graph B).
The LCMS traces (graph B) of each peptide incubated with Trypsin were recorded at the following successive times: 0, 5, 12, 21, 45 and 90 min.
From these data, the intensity of the mass corresponding to the entire peptide sequence (graph C) was integrated to extract kinetic values. 
LCMS traces of RED-BID-Cys 1a in presence of Trypsin
Circular Dichroism
Samples were prepared in two different solvent systems (30% TFE:H 2 O, 30% CH 3 CN:water) to concentrations between 10 -20 μM (Figure S 23) . Considering the high number of hydrophobic residues in BID and S peptides, organic co-solvents were used to ensure good solubility and avoid aggregation at concentrations high enough for CD analyses. DMSO stocks of peptides were not used for CD due to its high absorbance below 230 nm.
The raw circular dichroism data obtained for the peptides was processed by the subtraction of the solvent signal and converted into a mean residue ellipticity: Calculation of % helicity was performed by the following equation: [4] = ( 0 + ) * (1 -)
Where:  H = Theoretical MRE for 100% helicity at 222 nm,  0 = Theoretical MRE for 100% helicity at 222 nm at 0 °C = -44000, (∂/∂T) = temperature dependence of infinite helix = +250, T = temperature in °C, x = 3, N r = number of residues in the peptide.
In both solvent systems, it is noteworthy that STA-peptides are more helical than REDpeptides or WT-peptides; with the exception of constrained S-Cys-peptides. The use of TFE as co-solvent in water enhances the -helicity of both series of peptides compared to the use of acetonitrile in water. The CD analyses show that STA-peptides can adopt a helical (and thus bioactive) conformation. The S peptides show a low helix propensity which is consistent with the observations of Hamachi [5] and hence TFE has a more dramatic effect.
BID peptides S peptides
A. RED-BID-Cys -1a 40% 29% RED-BID-hCys -1b 23% 24% STA-BID-Cys -3a 55% 42% STA-BID-hCys -3b 47% 43% WT-S -8 30% 15% OX-S-Cys -2c 0% 0% OX-S-hCys -2d 56% 23% STA-S-Cys -3c 9% 5% STA-S-hCys -3d 52% 20%
Molecular Modelling
Molecular Modelling allowed us to study two different features: -the influence of the maleimide cross-link on helicity was studied by modelling RED-BID-hCys 1b as the non constrained peptide model and STA-BID-Cys 3a as the stapled peptide model. -the length of the constraint ring on helicity was studied by modelling STA-S-Cys 3c
and STA-S-hCys 3d and WT-S 8 was used as a control.
Molecular Mechanics calculation
A hybrid MCMM conformational search was carried out on 1b, 3a, 8, 3c and 3d in a water medium using Macromodel software package from Schrödinger and the MMFF force field with the following restraint: the dihedral angles of each amino acid were restricted to -58° for ϕ and to -47° for ψ. The calculation was run to generate 1 000 conformer sets, of which the lowest energy conformer was retained for inspection. As anticipated, all lowest energy conformers adopted an -helical conformation and showing a complete series of -helical intramolecular hydrogen bonds ( 
Molecular Dynamics simulation
The molecular dynamics simulation was conducted using the Desmond software package from Schrödinger. The lowest-energy conformer of 1b, 3a, 8, 3c and 3d (generated by the MCMM calculation described above) was placed in a cubic cell, with the size adjusted to maintain a minimum distance of 10 Å to the cell boundary and soaked with an orthorhombic box of TIP3P using the System Builder module. The OPLS 2005 force field was used to model all peptide interactions. The system was equilibrated with the default protocol of Desmond then a NPT production simulation with all restraints removed was run at 300 K and 1 atm for 10 ns. Configurations were saved at 20 ps intervals.
The existence of hydrogen bonds was determined via a geometric criterion requiring a maximum donor (NH)-to-(O=C) acceptor distance of 2.5 Å and a maximum N-H-O=C angle of 30°.
Comparison between RED-BID-hCys 1b and STA-BID-Cys 3a
The intramolecular hydrogen bonds were monitored and displayed as a 2D graph ( The MD simulations clearly show that the total number of intramolecular H-bonds is greater in STA-BID-hCys than in RED-BID-Cys, illustrating the increased stability of STA-BIDpeptides.
The occurrence of helical hydrogen bonds was monitored and displayed as a 2D graph (Figure S 26) . The X axis corresponds to the simulation time. The Y axis reports the presence, 1, or the absence, 0, of intramolecular hydrogen bonds within the peptide. The analysis of H-bonds showed that helical H-bonds are more prominent during the simulation in STA-BID-hCys than in RED-BID-Cys. The MD experiments confirm that the -helical conformation of STA-BID peptides is more stable than RED-BID peptides, consistent with CD analyses.
Comparison between WT-S 8, STA-S-Cys 3c and STA-S-hCys 3d
The intramolecular hydrogen bonds were monitored and displayed as a 2D graph (Figure S 27). The X axis corresponds to the simulation time. The Y axis reports the total number of intramolecular hydrogen bonds within the peptide. The analysis of H-bonds showed that helical H-bonds are more prominent during the simulation and along the entire sequence in STA-S-hCys than in WT-S and STA-S-Cys. The
Fluorescence Anisotropy
The fluorescein-labelled FITC-Ahx-NOXA B (75-92) was purchased from Severn Biotech Ltd, the labelled BODIPY-TMR-BAK (572-586) was purchased from ProteoGenix and the fluorescein-labelled FITC-Ahx-BID (80-102) was synthesised and purified as stated previously. [6] Fluorescence anisotropy assays were performed in 384-well black plates (Greiner Bio-one). Each experiment was run in triplicate and fluorescence anisotropy was measured using a Perkin Elmer EnVisionTM 2103 MultiLabel plate reader. Fluorescein labelled peptides used an excitation and emission wavelength of 480 nm (30 nm bandwidth) and 535 nm (40 nm bandwidth) respectively (polarised dichroic mirror at 505 nm) whilst BODIPY labelled peptides used an excitation and emission wavelength of 531 nm (25 nm bandwidth) and 595 nm (60 nm bandwidth) respectively (polarised dichroic mirror at 555 nm).
Experiments were performed in different assay buffers according to the targeted protein and the tracer: -50 mM Tris buffer at pH 7.4, containing 150 mM NaCl and 0.61% of Triton X-100 for FITC-BID/Mcl-1. -50 mM phosphate buffer at pH 7.5, containing 200 mM NaCl and 0.02 mg.mL -1 bovine serum albumin (BSA) for BODIPY-BAK/Bcl-x L . -50 mM phosphate buffer at pH 7.5, containing 200 mM NaCl and 0.05% of tween for FITC-NOXA B/Mcl-1.
20 µL of assay buffer were first added to each well.
For each competition assay, 20 µL of a solution of -helix mimetics (1 mM in 90:10 (v/v) assay buffer: DMSO) were added to the first column. The solution was well mixed and 20 µL were taken out and added to the next column and so on. This operation consisted on serial dilution of the peptides across the plate (24-points, 1/2 serial dilution). The tracer peptide and the targeted protein were added to each well to give a final concentration of 25 nM and 150 nM, respectively.
For each direct titration assay, 20 µL of a solution of the protein (60 µM in assay buffer) were added to the first column. The solution was well mixed and 20 µL were taken out and added to the next column and so on. This operation consisted on serial dilution of the protein across the plate (24-points, 1/2 serial dilution). The tracer peptide (225 nM stock solution in assay buffer) was then added to each well to give a final concentration of 75 nM of tracer peptide and 15 µM of the protein.
For control wells in both assays, the tracer peptide was replaced with an identical volume of assay buffer. The total volume in each well was 60 μL. Plates were read after 1 h of incubation at room temperature.
The data for both the P (perpendicular intensity) and S (parallel (same) intensity) channels, resulting from this measurement and corrected by subtracting the corresponding control wells, were used to calculate the intensity and anisotropy for each well following Equations 1 and 2:
(Equation 1)
Where I is the total intensity, G is an instrument factor which was set to 1 for all experiments and r is the anisotropy.
The average anisotropy (across three experimental replicates) and the standard deviation of these values were then calculated and fit to a sigmoidal logistic model (Equation 3) using OriginPro 9.0 which provided the IC50 and error values. 
